The Fort Worth Press - US greenlights pig kidney transplant trials

USD -
AED 3.673042
AFN 70.457366
ALL 90.829694
AMD 390.071248
ANG 1.79784
AOA 914.503981
ARS 1062.288118
AUD 1.592357
AWG 1.8025
AZN 1.70397
BAM 1.798023
BBD 2.014158
BDT 121.204321
BGN 1.80766
BHD 0.374718
BIF 2956.469777
BMD 1
BND 1.330453
BOB 6.893128
BRL 5.734604
BSD 0.997564
BTN 86.069409
BWP 13.600552
BYN 3.264629
BYR 19600
BZD 2.003769
CAD 1.44215
CDF 2875.000362
CHF 0.883969
CLF 0.024205
CLP 928.595725
CNY 7.24925
CNH 7.257904
COP 4161.98575
CRC 498.735923
CUC 1
CUP 26.5
CVE 101.3698
CZK 23.121404
DJF 177.641921
DKK 6.897804
DOP 62.845323
DZD 133.069179
EGP 50.271662
ERN 15
ETB 131.5567
EUR 0.91935
FJD 2.29945
FKP 0.774133
GBP 0.774054
GEL 2.77504
GGP 0.774133
GHS 15.462193
GIP 0.774133
GMD 70.503851
GNF 8626.062974
GTQ 7.686509
GYD 209.321995
HKD 7.77505
HNL 25.52057
HRK 6.966804
HTG 130.737761
HUF 367.460388
IDR 16526
ILS 3.717104
IMP 0.774133
INR 85.994504
IQD 1306.826017
IRR 42112.503816
ISK 133.203814
JEP 0.774133
JMD 156.129625
JOD 0.70904
JPY 149.34504
KES 129.037003
KGS 85.905104
KHR 3995.403356
KMF 455.303794
KPW 900
KRW 1465.780383
KWD 0.30813
KYD 0.831349
KZT 501.907607
LAK 21597.793611
LBP 89385.336704
LKR 295.628591
LRD 199.512756
LSL 18.143599
LTL 2.95274
LVL 0.60489
LYD 4.799816
MAD 9.578764
MDL 17.995863
MGA 4663.755459
MKD 56.566307
MMK 2099.772117
MNT 3482.180098
MOP 7.986762
MRU 39.551368
MUR 45.303741
MVR 15.403739
MWK 1729.717306
MXN 20.239204
MYR 4.423039
MZN 63.903729
NAD 18.143599
NGN 1550.000344
NIO 36.708803
NOK 10.571345
NPR 137.710871
NZD 1.744897
OMR 0.382652
PAB 0.997564
PEN 3.615629
PGK 4.106642
PHP 57.340504
PKR 279.514135
PLN 3.878557
PYG 7976.097449
QAR 3.636313
RON 4.597704
RSD 107.754539
RUB 84.001011
RWF 1435.348196
SAR 3.751231
SBD 8.421986
SCR 14.245001
SDG 601.000339
SEK 10.137385
SGD 1.333404
SHP 0.785843
SLE 22.803667
SLL 20969.501083
SOS 570.075845
SRD 36.347504
STD 20697.981008
SVC 8.729028
SYP 13001.856869
SZL 18.128246
THB 33.916038
TJS 10.898276
TMT 3.5
TND 3.093726
TOP 2.342104
TRY 37.790368
TTD 6.778212
TWD 32.990367
TZS 2646.012411
UAH 41.431303
UGX 3657.090324
UYU 42.15123
UZS 12909.216272
VES 68.22624
VND 25605
VUV 122.652127
WST 2.809789
XAF 603.040221
XAG 0.030272
XAU 0.000331
XCD 2.70255
XDR 0.749989
XOF 603.040221
XPF 109.639163
YER 246.075037
ZAR 18.23251
ZMK 9001.203587
ZMW 28.809009
ZWL 321.999592
  • NGG

    -1.2300

    63.85

    -1.93%

  • RBGPF

    0.0200

    67.02

    +0.03%

  • BP

    -0.2000

    34.55

    -0.58%

  • RIO

    -0.9300

    61.99

    -1.5%

  • GSK

    -0.1700

    39.24

    -0.43%

  • AZN

    -1.5900

    74.93

    -2.12%

  • BTI

    -0.2400

    40.83

    -0.59%

  • VOD

    0.0300

    9.73

    +0.31%

  • CMSC

    0.0400

    23.16

    +0.17%

  • RYCEF

    0.0800

    10.38

    +0.77%

  • BCC

    -0.9700

    99.46

    -0.98%

  • JRI

    -0.0600

    12.99

    -0.46%

  • SCS

    -0.4200

    10.57

    -3.97%

  • RELX

    0.1200

    50.01

    +0.24%

  • CMSD

    0.0000

    23.16

    0%

  • BCE

    -0.3200

    22.7

    -1.41%

US greenlights pig kidney transplant trials
US greenlights pig kidney transplant trials / Photo: © AFP/File

US greenlights pig kidney transplant trials

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.

Text size:

United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.

Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.

United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.

The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.

The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.

Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.

"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.

Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.

Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.

Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.

United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.

Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.

She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.

D.Ford--TFWP